Comments
Loading...
Fate Therapeutics Earnings Estimates, EPS & Revenue | NASDAQ:FATE | Benzinga
Fate Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
May 8
EPS Estimate
$-0.460
Quarterly Revenue Estimate
$1.20M
Annual Revenue
(as of Dec 31)
(as of Dec 31)
$13.63M
Analyze the earnings history of Fate Therapeutics using advanced sorting and filters.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| FATE | Fate Therapeutics | -$0.47 | -$0.46 | — | — | $1.93M | $1.20M | — | — | 05/08/2025 | Get Alert |
| FATE | Fate Therapeutics | -$0.45 | -$0.43 | -$0.44 | -2.33% | $1.68M | $1.57M | $1.86M | 18.47% | 03/05/2025 | Get Alert |
| FATE | Fate Therapeutics | -$0.46 | -$0.42 | -$0.40 | 4.76% | $1.94M | $1.32M | $3.07M | 132.00% | 11/12/2024 | Get Alert |
| FATE | Fate Therapeutics | -$0.54 | -$0.47 | -$0.33 | 29.79% | $933.00K | $1.41M | $6.77M | 380.28% | 08/13/2024 | Get Alert |
| FATE | Fate Therapeutics | -$0.19 | -$0.49 | -$0.47 | 4.08% | $58.98M | $1.11M | $1.93M | 73.42% | 05/09/2024 | Get Alert |
| FATE | Fate Therapeutics | -$0.58 | -$0.52 | -$0.45 | 13.46% | $44.36M | $1.59M | $1.68M | 5.41% | 02/26/2024 | Get Alert |
| FATE | Fate Therapeutics | -$0.86 | -$0.57 | -$0.46 | 19.30% | $14.98M | $890.00K | $1.94M | 118.43% | 11/08/2023 | Get Alert |
| FATE | Fate Therapeutics | -$0.79 | -$0.59 | -$0.54 | 8.47% | $18.55M | $5.53M | $933.00K | -83.13% | 08/08/2023 | Get Alert |
| FATE | Fate Therapeutics | -$0.68 | -$0.62 | -$0.19 | 69.35% | $18.41M | $35.50M | $58.98M | 66.14% | 05/03/2023 | Get Alert |
| FATE | Fate Therapeutics | -$0.72 | -$0.86 | -$0.58 | 32.56% | $17.07M | $16.72M | $44.36M | 165.29% | 02/28/2023 | Get Alert |
| FATE | Fate Therapeutics | -$0.45 | -$0.89 | -$0.86 | 3.37% | $14.22M | $15.63M | $14.98M | -4.15% | 11/03/2022 | Get Alert |
| FATE | Fate Therapeutics | -$0.58 | -$0.82 | -$0.79 | 3.66% | $13.41M | $12.91M | $18.55M | 43.68% | 08/03/2022 | Get Alert |
| FATE | Fate Therapeutics | -$0.48 | -$0.76 | -$0.68 | 10.53% | $11.14M | $9.40M | $18.41M | 95.89% | 05/04/2022 | Get Alert |
| FATE | Fate Therapeutics | -$0.61 | -$0.67 | -$0.72 | -7.46% | $15.90M | $10.73M | $17.07M | 59.06% | 02/28/2022 | Get Alert |
| FATE | Fate Therapeutics | -$0.68 | -$0.58 | -$0.45 | 22.41% | $7.56M | $7.89M | $14.22M | 80.29% | 11/04/2021 | Get Alert |
| FATE | Fate Therapeutics | -$0.35 | -$0.53 | -$0.58 | -9.43% | $5.46M | — | $13.41M | — | 08/04/2021 | Get Alert |
| FATE | Fate Therapeutics | -$0.44 | -$0.43 | -$0.48 | -11.63% | $2.52M | $5.90M | $11.14M | 88.85% | 05/05/2021 | Get Alert |
| FATE | Fate Therapeutics | -$0.37 | -$0.39 | -$0.61 | -56.41% | $2.80M | $4.87M | $15.90M | 226.41% | 02/24/2021 | Get Alert |
| FATE | Fate Therapeutics | -$0.40 | -$0.36 | -$0.68 | -88.89% | $2.43M | $6.97M | $7.56M | 8.44% | 11/05/2020 | Get Alert |
| FATE | Fate Therapeutics | -$0.36 | -$0.27 | -$0.35 | -29.63% | $2.82M | $13.23M | $5.46M | -58.69% | 08/05/2020 | Get Alert |
| FATE | Fate Therapeutics | -$0.30 | -$0.39 | -$0.44 | -12.82% | $2.63M | $1.80M | $2.52M | 39.72% | 05/11/2020 | Get Alert |
Fate Therapeutics (FATE) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q4 | 2025-03-05 | $-0.44 | $-0.43 | -2.33 % |
| Q3 | 2024-11-12 | $-0.40 | $-0.42 | 4.76 % |
| Q2 | 2024-08-13 | $-0.33 | $-0.47 | 29.8 % |
| Q1 | 2024-05-09 | $-0.47 | $-0.49 | 4.08 % |
Fate Therapeutics (FATE) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q4 | 2025-03-05 | $1.86M | $1.57M | 18.5 % |
| Q3 | 2024-11-12 | $3.07M | $1.33M | 132.0 % |
| Q2 | 2024-08-13 | $6.77M | $1.41M | 380.3 % |
| Q1 | 2024-05-09 | $1.93M | $1.11M | 73.4 % |
FAQ
When is Fate Therapeutics (NASDAQ:FATE) reporting earnings?
Fate Therapeutics (FATE) is scheduled to report earnings on May 8, 2025. The last reported earnings were for reported on March 5, 2025 for Q4.
What were the latest earnings per share (EPS) for Fate Therapeutics (NASDAQ:FATE)?
The Actual EPS was $-0.44, which missed the estimate of $-0.43.
What were Fate Therapeutics’s (NASDAQ:FATE) revenues?
The Actual Revenue was $1.9M, which beat the estimate of $1.6M.
Browse earnings estimates, EPS, and revenue on all stocks.